Judson Taylor
Technik-/Wissenschafts-/F&E-Leiter bei DIANTHUS THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Judson Taylor
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Holding Company | Biotechnology | 31 | |
| Public Company | Biotechnology | 22 | |
| Subsidiary | Pharmaceuticals: Major | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Judson Taylor
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Human Resources Officer | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OKYO PHARMA LIMITED | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Investor Relations Contact | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | Founder Investor Relations Contact | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Chief Executive Officer Founder | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| University of Baroda | College/University | Doctorate Degree Doctorate Degree | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal Director of Finance/CFO | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President Corporate Officer/Principal | |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
| TREVENA, INC. | Pharmaceuticals: Major | Chairman Founder | |
| CELYAD ONCOLOGY SA | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Founder Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Chairman Founder Director/Board Member Chief Executive Officer Director/Board Member | |
| ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO Director/Board Member | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Viridian LLC
 Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Executive Officer Founder | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| NUVATION BIO INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 38 |
| Irland | 5 |
| Kanada | 3 |
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
Sektoral
| Health Technology | 42 |
| Consumer Services | 6 |
| Retail Trade | 2 |
| Commercial Services | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 216 |
| Corporate Officer/Principal | 136 |
| Independent Dir/Board Member | 74 |
| Chief Tech/Sci/R&D Officer | 42 |
| Undergraduate Degree | 41 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Andrew von Eschenbach | 33 |
| Lonnie Moulder | 31 |
| Anne McGeorge | 25 |
| Alison Lawton | 25 |
| Anthony Adam Rosenberg | 23 |
| Sean Murphy | 22 |
| George Martin | 21 |
| Debasish Francois Roychowdhury | 18 |
| Gary Jacob | 16 |
| Richard Daly | 15 |
| Kurt Graves | 15 |
| Jessica Hopfield | 14 |
| Gary Sender | 14 |
| Kunwar Shailubhai | 14 |
| Gary Gemignani | 13 |
- Börse
- Insiders
- Judson Taylor
- Unternehmensverbindungen
